Abstract:Yingying Shen, 1, 2, &ast Junmin Cao, 3, &ast Tonglin Hu, 1, 2 Xiawan Yang, 1, 2 Yuechao Zhao, 1, 2 Yiping Shen, 1, 2 Baodong Ye, 1, 2 Yunsong Yu, 4 Dijiong Wu 1, 2 1 Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, People's Republic of China; 2 National Traditional Chinese Medicine Clinical Research Base (Hematology), Hangzhou, Zhejiang, People's Republic of China; 3 Department of Clinical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, People's Republic of China; 4 Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dijiong Wu, Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, People's Republic of China, Tel +86-0571-86620325, Email Yunsong Yu, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310024, People's Republic of China, Tel +8613805790432, Email Background: Carbapenem-resistant P. aeruginosa (CRPA) is a common hospital-acquired bacterium. It exhibits high resistance to many antibiotics, including ceftazidime/avibactam and cefteolozane/tazobactam . The presence of carbapenem-resistant genes and co-existence Klebsiella pneumoniae carbapenemase (KPC) and metallo-β-lactamases (MBLs) further inactivated all β-lactams. Understanding the resistance genes of CRPA can help in uncovering the resistance mechanism and guiding anti-infective treatment. Herein, we reported a case of perianal infection with hypervirulent ST463 Pseudomonas aeruginosa . Case Presentation: The case is a 32-year-old acute myeloid leukemia (AML) patient with fever and septic shock during hematopoietic stem cell transplantation (HSCT), and the pathogen was finally identified as a highly virulent sequence type 463 (ST463) P. aeruginosa harboring carbapenem-resistant genes bla AFM-1 and bla KPC-2 , which was detected in the bloodstream and originated from a perianal infection. The strain was resistant to ceftazidime/avibactam but successfully treated with polymyxin B , surgical debridement, and granulocyte engraftment after HSCT. The AML was cured during the 19-month follow-up. Conclusion: This case emphasizes the importance of metagenomic next-generation sequencing (mNGS) and whole-genome sequencing (WGS) in identifying microbes with rare resistant genes, and managing CRPA, especially in immunocompromised patients. Polymyxin B may be the least resistant option. Keywords: carbapenem-resistant pseudomonas aeruginosa, bla AFM , bla KPC , ST463 As one of the most common nosocomial bacteria, Pseudomonas aeruginosa often causes infections associated with blood, urinary tract, skin and soft tissue. 1 In the treatment of multidrug-resistant P. aeruginosa (MDR-PA), carbapenems have proven to be the most effective antibiotics. However, the extensive use of carbapenems has resulted in a significant increase in carbapenem-resistant P. aeruginosa (CRPA) strains. 2 The increasing prevalence of CRPA has further elevated the mortality rate, with a 30% 30-day mortality rate even after appropriate treatment, 2 which was higher in hematological disorder patients with granulocytopenia. Hematopoietic stem cell transplantation (HSCT) is a crucial treatment for curing hematologic malignancies. Infections often occur during the neutropenic phase of HSCT, which may lead to graft failure or life-threatening complications. In particularly, early-onset severe CRPA infection during HSCT will negatively impact the long-term prognosis because it poses a significant constraint on therapeutic strategies. Therefore, it is important to further understand the drug-resistance mechanisms of P. aeruginosa and make rational choices for anti-infection strategies. Herein, we isolated a strain of bla KPC-2 ST463 CRPA, resistant to ceftazidime/avibactam , from the bloodstream of a HSCT patient. The final result of whole-genome sequencing (WGS) analysis indicated that this strain simultaneously produces Klebsiella pneumoniae carbapenemase (KPC) -Abstract Truncated-

Emergence of Bla KPC-33-Harboring Hypervirulent ST463 Pseudomonas Aeruginosacausing Fatal Infections in China

A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.

Emergence of carbapenem-resistant Serotype K1 hypervirulent Klebsiella pneumoniae (hvKP) strains in China.

The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in Zhejiang Province, China

Emergence of Klebsiella Pneumoniae Carbapenemase-Producing Escherichia Coli Sequence Type 131 in Hangzhou, China

Transmission Dynamics of Carbapenem-Resistant Klebsiella Pneumoniae Sequence Type 11 Strains Carrying Capsular Loci KL64 and Rmpa/rmpa2 Genes

Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing P. aeruginosa Sequence Type 463, Associated With High Mortality Rates in China: A Retrospective Cohort Study

Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne blaKPC-2 and Virulence-Related Genes

Pseudomonas aeruginosa strains isolated from environments and patients analysed by cgMLST: The dominance of the emerging high-risk clone ST463 from intensive care unit in East China

Emerging and Re-Emerging KPC-producing Hypervirulent Pseudomonas Aeruginosa ST697 and ST463 Between 2010 and 2021

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China

Successful Treatment of an AML Patient Infected with Hypervirulent ST463 Pseudomonas Aeruginosa Harboring Rare Carbapenem-Resistant Genes blaAFM-1 and blaKPC-2 Following Allogeneic Hematopoietic Stem Cell Transplantation

Emergence and clonal dissemination of KPC-3-producing Pseudomonas aeruginosa in China with an IncP-2 megaplasmid

In vivo acquisition of blaKPC-2 with low biological cost in blaAFM-1-harboring ST463 hypervirulent Pseudomonas aeruginosa from a patient with hematologic malignancy

Carbapenem-Resistant Hypervirulent ST11 Klebsiella Pneumoniae Colonization in Zhejiang, China: an Epidemiological, Genomic and Functional Study

bla KPC-2 overexpression and bla GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China

Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella Pneumoniae Clone in China.

Fusion Plasmid Enhanced the Endemic Extensively Drug Resistant Klebsiella Pneumoniae Clone ST147 Harbored Blaoxa-48 to Acquire the Hypervirulence and Cause Fatal Infection

Evolutionary adaptation of KPC-2-producing Pseudomonas aeruginosa high-risk sequence type 463 in a lung transplant patient

A Potential High-Risk Clone of Pseudomonas aeruginosa ST463

An Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit of a Major Teaching Hospital in Chongqing, China